Peer Review History
| Original SubmissionJune 14, 2022 |
|---|
|
PONE-D-22-17033Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative studyPLOS ONE Dear Dr. Bulterys, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Joel Msafiri Francis, MD, MS, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript. 3. Thank you for stating the following in your Competing Interests section: "NO authors have competing interests" Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study. Congratulations on your study and development of this manuscript for publication. A study of this nature potentially can add to the body of knowledge on strategies to increase uptake of HIV testing among men in SSA. Below I offer comments that could make the manuscript more improved and valuable. GENERAL COMMENT: Overall the study was well designed and implemented and the manuscript is well written. However I have few comments below to improve the manuscript. 1. Abstract: I would like to suggest that the authors should be consistent in using the words:“ Facilitators vs. motivators”. These words are used interchangeable through out the manuscript. See line 62 on page 3, line 112 on pages 5, and line 122 on pages 6, etc. 2. Introduction: The following sentence mentions “…regarding HIVST acceptability, barriers….”. Did the authors also assessed ”Motivators/facilitators?. If yes, it is not mentioned. See line 96 page 5. 3. Data collection and analysis: Did JM conduct all the interviews alone? What about a note taker? See line 125 on page 6. 4. It seems JM (male interviewer) conducted interviews for women. Could this be a limitation for women to express themselves freely on such sensitive issues to a male interviewer compared to a female interviewer? Could authors clarify on this observation? See line 125 on page 6. 5. In principal translations should be done by a qualified translated. Does this imply that JM is a qualified Translator? Could authors clarify on this observation? See line 129 on page 6. 6. The authors should mention what was the role of using the NVivo software in this study. See line 130 on page 6. 7. The authors mentioned that all FGDs and IDIs were double-coded to assess inter-coder reliability. Could authors provide the results of the inter-coder reliability? See 131 on page 6. 8. The authors also mentioned that they used the Social ecological model to organize the research questions and findings. However, It was very difficult to follow how the authors operationalize their findings and what was presented in Figure II. I suggest that the authors should align their findings and what is presented in the current Figure II. An additional description accompanying the Figure II will be very beneficial to readers. See line 132 on page 6 and line 170 on page 9. 9. The authors reported that they used deductive thematic analysis. The authors should provide justification of using the deductive thematic analysis compared to inductive thematic analysis. See line 134 on page 6. 10. The authors did not mention whether FGDs and IDIs data were analyzed jointly or separately and combined later during interpretation. 11. The authors did not mention how they applied reflexivity and rigor in terms of trustworthness, dependability, credibility and transferability throughout the data analysis from data collection to interpretation of the findings. 12. Ethical approval: The authors should provide ethics clearance certificate ID for both Ethics committees. See line 137 on page 6. 13. Authors did not mention measures taken to protect confidentiality and anonymity in this study. 14. Results: It was unnecessary to present median & IQR in a qualitative study. Could authors clarify on this observation? See line 144 and 148 on page 7. 15. The following sentence….”did not know HIV could be detected using saliva”. I think using the word ‘saliva’ is not correct in the HIVST perspective. What is used is oral fluid from the mucosa of the mouth. I suggest this should be corrected. See line 176 on page 9. 16. The following quote: “ HIV self-test is like a fishing net…their partners to the hospital to test”. This quote does not support what is described above. Authors should justify the use of the quote or present a relevant quote. See lines 187-190 on page 10. 17. Conclusion: Is missing in the main manuscript but presented in the abstract. Authors should add their conclusion in the main manuscript. 18. Authors have mentioned among other interventions “ financial incentives”. Despite existing literature supporting this intervention, I was wondering if this would be sustainable in case of scaling-up to the general population. 19. One of the key barriers for uptake of HIVST is the high cost of buying the HIV self-test kits. I was wondering if the authors assessed this common barrier. Reviewer #2: Comments to the Author Summary: Overall these study findings add very little evidence on secondary distribution of HIVST kits in an ante natal setting. I would recommend that the authors made major revisions. These include contexualising how their findings are different from other studies conducted in other countries in Africa. Detailed comments are below. Abstract: 1. Specify with whom FGDs and IDI’s were conducted (men, women etc) Introduction: 1. I recommend providing stats on HIV testing in Uganda. 2. Briefly describe what testing is like among men and women. 3. Need to specify what the current status of HIVST in Uganda from a policy perspective. 4. The last paragraph is not clear what you are trying to establish. Many studies have already been done on acceptability and barriers. Many conducted on secondary distribution within ANC care. How is yours different? Methods: 1. How was low risk for IPV established? 2. How many FGDs, how many IDI’s. 3. There are a lot of elements from the Consolidated Criteria for Reporting Qualitative Studies (COREQ) missing from the methods (https://academic.oup.com/intqhc/article/19/6/349/1791966). I strongly encourage the authors to consult the COREQ criteria and ensure that elements are covered 4. For each ‘finding’ (new paragraph), it would be preferable to provide some sense of how common it was, and among whom (women, men,). Doesn’t have to be as specific as the “Most (85%)…” under the first finding (although that level of specificity is helpful there). This will give a better sense, at the end, for a sort of pros/cons assessment which is currently missing – high acceptability and perceived effectiveness, and low concerns? Or more equal levels of both? Results: 1. Information in first paragraph should be in the methods section 2. Where the men and women interviews also held by status? Refer to 2-3 line of first paragraph under methods. 3. Under “low awareness of HIVST”, there is mention of saliva. Context needs to be provided in the introduction and discussion of HIVST in Uganda, including tests used. Discussion: 1. Results are comparative of other studies. How is this study different? 2. Most of the discussion summarises the results. Doesn’t offer much in terms of the strategies identified could be integrated. 3. To posit this work as a formative qualitative study, more information is needed to contextualize why this study was specifically needed, how it informed intervention development, and how the newly formed intervention would be subsequently used. qualitative study. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Angela Tembo ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study PONE-D-22-17033R1 Dear Dr. Bulterys, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Joel Msafiri Francis, MD, MS, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am pleased that the authors have addressed all comments that I suggested and the manuscript can be accepted for publication. Reviewer #2: Dear Editor, The authors have adequately addressed the comments. The paper is now of publishable standard. I would however recommend that the authors consider repositioning the “re-envisioned cascade” to recommendations section. Thank you ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Angela Tembo ********** |
| Formally Accepted |
|
PONE-D-22-17033R1 Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study Dear Dr. Bulterys: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Joel Msafiri Francis Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .